Skip to content

ABioGram – Integrated AMR Intelligence

A unified platform for real-time surveillance, analysis, and reporting of antimicrobial resistance data

Problems the system addresses

⚠️

Quality of every report

Susceptibility results influence antimicrobial therapy. Manual categorization and review increase the risk of inconsistency and overlooked special cases.

🔄📚

Consistent, current rules

Guidelines, nomenclature, and breakpoints change regularly. EUCAST, CLSI, and national criteria must be applied consistently across laboratories.

🔗📉

Data from report to AMR surveillance

Fragmented formats and manual exports limit comparability. Laboratories, clinicians, and analytics need one continuous flow of validated data.

Core capabilities

ABioGram brings susceptibility result control, information-system exchange, and AMR surveillance into one operational workflow.

Core capabilities
  • Categorization and control of every result using current breakpoints and expert rules
  • LIS/HIS integration via API or operation as a standalone web tool
  • Real-time AMR surveillance and analytics based on validated antibiograms
  • Reference support and process standardization for microbiologists and clinical pharmacologists

How ABioGram works

The system connects to the current laboratory workflow through the LIS/HIS or operates through its web interface.

  1. 01

    Receives data

    Uses pathogen identification, susceptibility results, and available metadata.

  2. 02

    Categorizes results

    Applies the selected guideline and the corresponding breakpoints.

  3. 03

    Validates the report

    Flags unusual combinations, discrepancies, and situations that require specialist attention.

  4. 04

    Returns and accumulates

    Sends the result to the LIS/HIS or web interface and stores validated data for AMR surveillance.

Key system differences

ABioGram is not a separate reporting utility. It becomes part of the continuous workflow of a laboratory, healthcare organization, or region.

ObjectiveABioGramLimitation of standalone tools
Every report in the operational flowCategorization, validation, and result generation happen without waiting for a periodic data export.Validation or analytics starts after export and does not affect the current result.
Closed digital loopThe result returns to the LIS/HIS, reducing manual transfer and connecting the laboratory with the clinical workflow.The solution remains a separate interface without automated delivery into the operational system.
Validated, comparable dataCommon criteria and expert rules are applied to every result across the organization or network.Reports rely on heterogeneous data that requires additional manual cleanup.
Real-time AMR surveillanceMetrics update as results arrive and remain available from patient and department level to a network or region.Analytics is limited to retrospective reports or cannot drill down to source data.

ABioGram combines control of every susceptibility result, LIS/HIS exchange, and AMR surveillance on validated data – from a single laboratory to a regional environment.

Technical capabilities

Criteria, expert rules, analytics, integration, and system operating conditions.

Supported guidelines and criteria

Categorization is available for the following guidelines:

  • Russian Recommendations for Antimicrobial Susceptibility Testing, 2026
  • Russian Recommendations for Antimicrobial Susceptibility Testing, 2025
  • EUCAST Version 16, 2026
  • EUCAST Version 15, 2025
  • EUCAST Fungi, Version 12, 2025
  • EUCAST Fungi, Version 11, 2024
  • EUCAST Version 14, 2024
  • EUCAST Fungi, Version 10, 2020
  • CLSI M100, 2024
  • CLSI M45
  • CLSI M27M44S-ED3:2022
  • EUCAST ECOFF

The criteria library is updated as new guidelines are released.

Expert rules and quality control
The maintained rule library flags unusual and questionable results and provides notices about indicator antibiotics, intrinsic resistance, possible inefficacy, and limitations of use. When required by the implementation scenario, reports can include reference comments for clinicians.
AMR surveillance and analytics
Metrics and trends update as data arrives. Users can analyze departments, service lines, periods, and other dimensions, compare periods, evaluate phenotypes and resistance markers, and drill down to source records. When included in the deployment, antibiogram history and result trends are available at patient level.
LIS/HIS integration
ABioGram exchanges data with LIS/HIS through an API or operates as a standalone web tool. The data exchanged and the return of results depend on the selected implementation scenario.
Deployment, scaling, and information security
The system can be deployed on premises within a healthcare organization’s or region’s secure environment, accounting for personal-data requirements. The architecture supports high result volumes, networks of institutions, and regional implementations.
Support and licensing
Support includes implementation assistance, consultation, updates, and workflow and rule configuration. Institutional delivery and a complete set of contracting documents are available. The system is listed in Russia’s Unified Register of Russian Software for Computers and Databases.

Additional information about ABioGram

Upon request, we provide information about system capabilities, deployment options, and LIS/HIS integration.